Figures computed from official regulatory filings — .
Statistical track record
Free accountWin rates, median returns and the proven-insider analysis come with a free account.
Create a free accountThis page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Rosetta Genomics Ltd.Listing on record | Buy | $5.7K | conv 20 | SEC | |
Rosetta Genomics Ltd.Listing on record | Buy | $14.3 | conv 19 | SEC | |
Rosetta Genomics Ltd.Listing on record | Buy | $6.3K | conv 20 | SEC | |
Rosetta Genomics Ltd.Listing on record | Buy | $21K | conv 35First in 12mo | SEC | |
Rosetta Genomics Ltd.Listing on record | Buy | $84 | conv 33First in 12mo | SEC | |
Rosetta Genomics Ltd.Listing on record | Buy | $6K | conv 20 | SEC | |
Rosetta Genomics Ltd.Listing on record | Buy | $1.5K | conv 20 | SEC | |
Rosetta Genomics Ltd.Listing on record | Buy | $336 | conv 33First in 12mo | SEC | |
Rosetta Genomics Ltd.Listing on record | Buy | $1.8K | conv 33First in 12mo | SEC | |
Rosetta Genomics Ltd.Listing on record | Buy | $7.5K | conv 34First in 12mo | SEC | |
Akari Therapeutics PlcListing on record | Buy | $15.6K | conv 34Cluster | SEC | |
Akari Therapeutics PlcListing on record | Buy | $85.5K | conv 56ClusterUnusual size | SEC | |
Akari Therapeutics PlcListing on record | Buy | $33.5K | conv 11 | SEC | |
Akari Therapeutics PlcListing on record | Buy | $16.1K | conv 10 | SEC | |
Akari Therapeutics PlcListing on record | Buy | $26.2K | conv 21First in 12mo | SEC |